Drugs / iEV
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07145294 | Mar → Jul 2025 overdue | cognitive impairment with or without cerebellar ataxia | Hongmei Wang | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | iEV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07145294 ↗ |
| Route | Intranasal | “Intranasal administration of iEV” NCT07145294 ↗ |